We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.82%
2 Technology 2.79%
3 Financials 2.26%
4 Consumer Discretionary 1.92%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EUFX
14776
DELISTED
ProShares Short Euro
EUFX
-19,631
Closed -$907K
ECOL
14777
DELISTED
US Ecology, Inc.
ECOL
-98,227
Closed -$4.7M
MACUW
14778
DELISTED
Mallard Acquisition Corp. Warrant
MACUW
-363,791
Closed -$31K
MGP
14779
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
-311,853
Closed -$12.1M
VOLT
14780
CALL
DELISTED
Volt Information Sciences, Inc.
VOLT
-13,700
Closed -$82K
FOE
14781
DELISTED
Ferro Corporation
FOE
-100,147
Closed -$2.18M
DHR.PRA
14782
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
-139
Closed -$272K
KLDO
14783
CALL
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
-143,500
Closed -$237K
KLDO
14784
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
-12,667
Closed -$21K
ZSAN
14785
DELISTED
Zosano Pharma Corporation
ZSAN
-814
Closed -$6K
STXB
14786
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
-265,434
Closed -$6.98M
MCA
14787
DELISTED
BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC
MCA
-13,433
Closed -$177K
DISCK
14788
CALL
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
-451,600
Closed -$11.3M
DISCK
14789
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
-526,494
Closed -$13.1M
DISCK
14790
PUT
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
-1,000,700
Closed -$25M
HMHC
14791
CALL
DELISTED
Houghton Mifflin Harcourt Company
HMHC
-43,000
Closed -$903K
HMHC
14792
DELISTED
Houghton Mifflin Harcourt Company
HMHC
-128,483
Closed -$2.7M
HMHC
14793
PUT
DELISTED
Houghton Mifflin Harcourt Company
HMHC
-43,700
Closed -$918K
MVP
14794
DELISTED
Roundhill Pro Sports, Media & Apparel ETF
MVP
-46,827
Closed -$577K
TLMD
14795
CALL
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
-14,200
Closed -$42K
ISBC
14796
DELISTED
Investors Bancorp, Inc.
ISBC
-198,247
Closed -$2.96M
BPMP
14797
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
-341,770
Closed -$5.78M
FLOW
14798
DELISTED
SPX FLOW, Inc.
FLOW
-117,112
Closed -$10.1M
PPGH
14799
DELISTED
Poema Global Holdings Corp. Class A Ordinary Share
PPGH
-2,501,212
Closed -$25M
PBCT
14800
DELISTED
People's United Financial Inc
PBCT
-50,454
Closed -$1.01M

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.